Medical materials

Publication
  • WFH CCS •
  • 24 April, 2025 •
  • •

A plain language summary of the association between joint health and patient reported quality of life outcomes using data from the efanesoctocog alfa Phase 3 clinical trial in adults and adolescents with severe haemophilia A

Christoph Königs, Doris Quon, Cedric Hermans, Emilie Gerard, Nana Kragh, Jérôme Msihid, Duygu Bozkaya, Linda Bystrická, Cecile LeCamus, Elena Santagostino, Annemieke Willemze, Annette von Drygalski

Available materials

Oral Presentation
Publication
  • WFH CCS •
  • 23 April, 2025 •
  • •

Plain language summary: Efanesoctocog alfa treatment outcomes over 3 years in adults & adolescents with severe haemophilia A in the long-term XTEND-ed study

Robert Klamroth, Stephanie P’ng, Sophie Susen, Davide Matino, Angela Weyand, Toshko Lissitchkov, Young-Shil Park, María Teresa Álvarez Román, Liqi Feng, Helena Palmborg, Jennifer Dumont , Elena Santagostino, Lara Mamikonian, Keiji Nogami

Available materials

Poster
Publication
  • WFH CCS •
  • 23 April, 2025 •
  • •

Plain language summary of two-year results of weekly efanesoctocog alfa treatment in children with severe haemophilia A: Interim analysis of the XTEND-ed phase 3 study

Lynn Malec, Beatrice Nolan, Anthony KC Chan, Manuela Albisetti, Sheng-Chieh Chou, Bulent Zulfikar, Mindy Simpson, Liqi Feng, Helena Palmborg, Graham Neill, Lydia Abad-Franch, Sriya Gunawardena, Karin Fijnvandraat

Available materials

Poster
Publication
  • WFH CCS •
  • 23 April, 2025 •
  • •

Efanesoctocog alfa for the perioperative management of dental surgery in participants with severe hemophilia A: 4 years of experience during the XTEND clinical program

Pratima Chowdary, Lynn Malec, Sophie Susen, Stephanie P’ng, Flora Peyvandi, Lara Mamikonian, Elena Santagostino, Graham Neill, Umer Khan, Linda Bystrická, Ming-Ching Shen

Available materials

Oral Presentation
Publication
  • WFH CCS •
  • 23 April, 2025 •
  • •

Long-term outcomes of prophylaxis with efanesoctocog alfa in adults and adolescents previously treated on demand: second interim analysis of XTEND-ed

Victor Jimenez-Yuste, Patricia Do Nascimento, Toshko Lissitchkov, Umer Khan, Linda Bystrická, Sriya Gunawardena, Helena Palmborg, Jennifer Dumont, Angela Weyand

Available materials

Poster
Publication
  • WFH CCS •
  • 23 April, 2025 •
  • •

SHINE study design: An interventional, open-label, Phase 4 study investigating changes in synovial hypertrophy in patients with haemophilia A on efanesoctocog alfa prophylaxis

Elena Santagostino, Linda Bystrická, Eveline Nüesch, Hong Wang, Sofia Bergenstråle, Claude Négrier

Available materials

Poster
Publication
  • WFH CCS •
  • 23 April, 2025 •
  • •

The A-MOVE study easily explained: the value of regular joint assessments in individuals with haemophilia

Nicolas Drillaud, Meriem Zidi, Markus Fusser, Aurelien Lebreton

Available materials

Poster
Symposium
  • WFH CCS •
  • 23 April, 2025 •
  • •

Advancing Haemophilia A Care With New Levels of Protection

Pratima Chowdary, Cedric Hermans, Maissaa Janbain

Available materials

Slides
Sign up for alerts